The National Academy of Medicine (ANM) of Venezuela expressed on October 27 its support at the beginning of the vaccination of adolescents with the vaccine developed by the Chinese pharmaceutical Sinopharm.
«The ANM supports the decision of the National Executive to vaccinate adolescents from 12 to 18 years with the Sinopharm vaccine, which according to suggestions expressed in three previous communications, should have been done before the start of classes and not wait for the first day of classes to proceed with the vaccination, ”he said in a statement.
Venezuela began vaccinating its adolescents with the Sinopharm vaccine on Monday, October 25. This vaccine is already used in children and adolescents between the ages of 3 and 17 in countries such as China and the United Arab Emirates, which authorized its use in July and August, respectively.
In other countries in the region, such as Chile, the process of immunizing children with the other inactivated vaccine from China, the CoronaVac de Sinovac.
Rejection of Abdala and Soberana 2 without evidence
Likewise, the ANM leadership reiterated its rejection of the administration to children between 2 and 12 years of Cuban vaccines Abala and Sovereign 2, still considered as candidates by the ANM, in the absence of recognition from an independent international regulatory body or the World Health Organization (WHO).
«Again we make an exhortation to the National Executive so that reconsider this decision to administer them to the Venezuelan population and even less to children, without informing parents that they are not vaccines and that doing so would be in compliance with an experimental phase, for which they should sign an informed consent, authorizing such a measure, “he added.
As part of the return to classes, the ANM also called for the vaccination of school personnel to ensure the continuous supply of water, soap and masks, planning classes with reduced capacity, and training teaching staff on biosafety standards.